View More View Less
  • 1 National Centre for Epidemiology Department of Hospital Epidemiology and Hygiene Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

As a result of the age-related changes, more elders live in long-term care facilities (LTCFs). Due to their susceptibility, infections and excess use of antimicrobials are common. The aim was to estimate the burden of infections and antimicrobial use in Hungarian LTCFs in order to increase the attention given to the prevention. European-wide point prevalence survey was conducted between April and May 2013. For each resident who had a signs and symptoms of an infection and/or treated with an antibacterial for systemic use a resident questionnaire was completed. Descriptive statistics were used to present the data. In total, 91 LTCFs with 11,823 residents were selected in this survey. The 252 residents had a sign/symptom of an infection (2.1%) and 156 received antimicrobial (1.3%). Skin and soft tissues (36.5%) was the most frequent infection. However, antimicrobials were mostly prescribed for respiratory tract infections (40.4%). The most common therapeutic antimicrobial agent (97.5%) belonged to the quinolone antibacterials (34.2%). Our results emphasise the need for targeted improvement of antimicrobial use including: reducing the use of quinolone antibacterials in order to prevent the spread of Clostridium difficile and other antimicrobial resistant microorganisms among institutionalized residents.

  • Hungarian Central Statistical Office: Demographic Yearbook. Hungarian Central Statistical Office, Budapest, 2011, pp. 22–26.

    '', in Demographic Yearbook. Hungarian Central Statistical Office , (2011 ) -.

  • Gavazzi, G., Krause, K.H.: Ageing and infection. Lancet Infect Dis 11, 659–666 (2002).

    Krause K.H. , 'Ageing and infection ' (2002 ) 11 Lancet Infect Dis : 659 -666.

  • Moro, M.L., Mongardi, M., Marchi, M., Taroni, F.: Prevalence of long-term care acquired infections in nursing and residential homes in the Emilia-Romagne region. Infection 35, 250–255 (2007).

    Taroni F. , 'Prevalence of long-term care acquired infections in nursing and residential homes in the Emilia-Romagne region ' (2007 ) 35 Infection : 250 -255.

    • Search Google Scholar
  • Nicolle, L.E.: Infection control in long-term care facilities. Clin Infect Dis 31, 752–756 (2000).

    Nicolle L.E. , 'Infection control in long-term care facilities ' (2000 ) 31 Clin Infect Dis : 752 -756.

    • Search Google Scholar
  • van Buul, L.W., van der Steen, J.T., Veenhuizen, R.B., Achterberg, W.P., Schellevis, F.G., Essink, R.T.G.M., van Benthem, B.H.B., Natsch, S., Hertogh, C.M.P.M.: Antibiotic use and resistance in long term care facilities. J Am Med Dir Assoc 13, 568.e1–13 (2012).

    Hertogh C.M.P.M. , 'Antibiotic use and resistance in long term care facilities ' (2012 ) 13 J Am Med Dir Assoc : 1 -13.

    • Search Google Scholar
  • Elizaga, M.L., Weinstein, R.A., Hayden, M.K.: Patients in long-term care facilities: A reservoir for vancomycin-resistant Enterococci. Clin Infect Dis 34, 441–446 (2002).

    Hayden M.K. , 'Patients in long-term care facilities: A reservoir for vancomycin-resistant Enterococci ' (2002 ) 34 Clin Infect Dis : 441 -446.

    • Search Google Scholar
  • Bergman, P., Hogan, D.B., Fox, R.A.: The atypical presentation of infection in old age. Age Ageing 16, 201–207 (1987).

    Fox R.A. , 'The atypical presentation of infection in old age ' (1987 ) 16 Age Ageing : 201 -207.

    • Search Google Scholar
  • Mehr, D.R., Binder, E.F., Kruse, R.L., Zweig, S.C., Madsen, R.W., D’Agostino, R.B.: Clinical findings associated with radiographic pneumonia in nursing home residents. J Fam Pract 50, 931–937 (2001).

    D’Agostino R.B. , 'Clinical findings associated with radiographic pneumonia in nursing home residents ' (2001 ) 50 J Fam Pract : 931 -937.

    • Search Google Scholar
  • Metlay, J.P., Kapoor, W.N., Fine, M.J.: Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. J Am Dir Med Assoc 278, 1440–1445 (1997).

    Fine M.J. , 'Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination ' (1997 ) 278 J Am Dir Med Assoc : 1440 -1445.

    • Search Google Scholar
  • European Centre for Disease Prevention and Control (ECDC): Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities, May–September 2010. Stockholm: ECDC; 2014. Available from: http://www.ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobialconsumption-point-prevalence-survey-long-term-care-facilities-2010.pdf

    '', in Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities, May–September 2010. Stockholm: ECDC , (2014 ) -.

  • European Centre for Disease Prevention and Control (ECDC): Point prevalence surveys of healthcare-associated infections and antimicrobial use in European long-term care facilities, April–May 2013. Stockholm: ECDC; 2014. Available from: http://www.ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-point-prevalencesurvey-long-term-care-facilities-2013.pdf

    '', in Point prevalence surveys of healthcare-associated infections and antimicrobial use in European long-term care facilities, April–May 2013. Stockholm: ECDC , (2014 ) -.

  • McGeer, A., Campbell, B., Emori, T.G., Hierholzer, W.J., Jackson, M.M., Nicolle, L.E.: Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 19, 1–7 (1991).

    Nicolle L.E. , 'Definitions of infection for surveillance in long-term care facilities ' (1991 ) 19 Am J Infect Control : 1 -7.

    • Search Google Scholar
  • World Health Organization (WHO): The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Geneva: WHO; 2013. Available from: http://www.who.int/classifications/atcddd/en/

    '', in The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Geneva: WHO , (2013 ) -.

  • Eikelenboom-Boskamp, A., Cox-Claessens, J.H.M., Boom-Poels, P.G.M., Drabbe, M.I.J., Koopmans, R.T.C.M., Voss, A.: Three-year prevalence of healthcare-associated infections in Dutch nursing homes. J Hosp Infect 78, 59–62 (2011).

    Voss A. , 'Three-year prevalence of healthcare-associated infections in Dutch nursing homes ' (2011 ) 78 J Hosp Infect : 59 -62.

    • Search Google Scholar
  • Cotter, M., Donlon, S., Roche, F., Byrne, H., Fitzpatrick, F.: Healthcare-associated infection in Irish long-term care facilities: results from the First National Prevalence Study. J Hosp Infect 80, 212–216 (2012).

    Fitzpatrick F. , 'Healthcare-associated infection in Irish long-term care facilities: results from the First National Prevalence Study ' (2012 ) 80 J Hosp Infect : 212 -216.

    • Search Google Scholar
  • Eilers, R., Veldman-Ariesen, M.J., Haenen, A., van Benthem, B.H.: Prevalence and determinants associated with healthcare-associated infections in long-term care facilities (HALT) in the Netherlands, May to June, 2010. Euro. Surveill 17, pii: 20252 (2012).

    Benthem B.H. , 'Prevalence and determinants associated with healthcare-associated infections in long-term care facilities (HALT) in the Netherlands, May to June, 2010 ' (2012 ) 17 Euro. Surveill : 20252 -.

    • Search Google Scholar
  • Heudorf, U., Boehlcke, K., Schade, M.: Healthcare-associated infections in long-term care facilities (HALT) in Frankfurt am Main, Germany, January to March 2011. Euro. Surveill 17, pii: 20256 (2012).

    Schade M. , 'Healthcare-associated infections in long-term care facilities (HALT) in Frankfurt am Main, Germany, January to March 2011 ' (2012 ) 17 Euro. Surveill : 20256 -.

    • Search Google Scholar
  • Eriksen, H.M., Iversen, B.G., Aavitsland, P.: Prevalence of nosocomial infections and use of antibiotics in long-term care facilities in Norway, 2002 and 2003. J Hosp Infect 57, 316–320 (2004).

    Aavitsland P. , 'Prevalence of nosocomial infections and use of antibiotics in long-term care facilities in Norway, 2002 and 2003 ' (2004 ) 57 J Hosp Infect : 316 -320.

    • Search Google Scholar
  • Andersen, B.M., Rasch, M.: Hospital-acquired infections in Norwegian long-term care institutions. A three-year survey of hospital-acquired infections and antibiotic treatment in nursing/residential homes, including 4500 residents in Oslo. J Hosp Infect 46, 288–296 (2000).

    Rasch M. , 'Hospital-acquired infections in Norwegian long-term care institutions. A three-year survey of hospital-acquired infections and antibiotic treatment in nursing/residential homes, including 4500 residents in Oslo ' (2000 ) 46 J Hosp Infect : 288 -296.

    • Search Google Scholar
  • Loeb, M.B., Craven, S., McGeer, A.J., Simor, A.E., Bradley, S.F., Low, D.E., Armstrong-Evans, M., Moss, L.A., Walter, S.D.: Risk factors for resistance to antimicrobial agents among nursing homes residents. Am J Epidemiol 157, 40–47 (2003).

    Walter S.D. , 'Risk factors for resistance to antimicrobial agents among nursing homes residents ' (2003 ) 157 Am J Epidemiol : 40 -47.

    • Search Google Scholar
  • Blix, H.S., Bergman, J., Schjott, J.: How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes. Pharmacoepidemiol Drug Saf 19, 1025–1030 (2010).

    Schjott J. , 'How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes ' (2010 ) 19 Pharmacoepidemiol Drug Saf : 1025 -1030.

    • Search Google Scholar
  • McClean, P., Hughes, C., Tunney, M., Goossens, H., Jans, B.: Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother 66, 1609–1616 (2011).

    Jans B. , 'Antimicrobial prescribing in European nursing homes ' (2011 ) 66 J Antimicrob Chemother : 1609 -1616.

    • Search Google Scholar
  • D’Agata, E., Mitchell, S.L.: Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 168, 357–362 (2008).

    Mitchell S.L. , 'Patterns of antimicrobial use among nursing home residents with advanced dementia ' (2008 ) 168 Arch Intern Med : 357 -362.

    • Search Google Scholar
  • Deshpande, A., Pasupuleti, V., Thota, P., Pant, C., Rolston, D.D., Sferra, T.J., Hernandez, A.V., Donskey, C.J.: Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 68, 1951–1961 (2013).

    Donskey C.J. , 'Community-associated Clostridium difficile infection and antibiotics: a meta-analysis ' (2013 ) 68 J Antimicrob Chemother : 1951 -1961.

    • Search Google Scholar
  • Marwick, C.A., Yu, N., Lockhart, M.C., McGuigan, C.C., Wiuff, C., Davey, P.G., Donnan, P.T.: Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control. J Antimicrob Chemother 68, 2927–2933 (2013).

    Donnan P.T. , 'Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control ' (2013 ) 68 J Antimicrob Chemother : 2927 -2933.

    • Search Google Scholar
  • Mylotte, J.M., Keagle, J.: Benchmarks for antibiotic use and cost in long-term care. J Am Geriatr Soc 53, 1117–1122 (2005).

    Keagle J. , 'Benchmarks for antibiotic use and cost in long-term care ' (2005 ) 53 J Am Geriatr Soc : 1117 -1122.

    • Search Google Scholar
  • Pakyz, A.L., Dwyer, L.L.: Prevalence of antimicrobial use among United States nursing home residents: results from a national survey. Infect Control Hosp Epidemiol 31, 661–662 (2010).

    Dwyer L.L. , 'Prevalence of antimicrobial use among United States nursing home residents: results from a national survey ' (2010 ) 31 Infect Control Hosp Epidemiol : 661 -662.

    • Search Google Scholar
  • Latour, K., Catry, B., Broex, E., Vankerckhoven, V., Muller, A., Stroobants, R., Goossens, H., Jans, B.: Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey. Pharmacoepidemiol Drug Saf 21, 937–944 (2012).

    Jans B. , 'Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey ' (2012 ) 21 Pharmacoepidemiol Drug Saf : 937 -944.

    • Search Google Scholar
  • Fleming, A., Browne, J., Byrne, S.: The effect of interventions to reduce potentially inappropriate antibiotic prescribing in long-term care facilities: a systematic review of randomised controlled trials. Drugs Aging 30, 401–408 (2013).

    Byrne S. , 'The effect of interventions to reduce potentially inappropriate antibiotic prescribing in long-term care facilities: a systematic review of randomised controlled trials ' (2013 ) 30 Drugs Aging : 401 -408.

    • Search Google Scholar
  • McClean, P., Tunney, M., Gilpin, D., Parsons, C., Hughes, C.: Antimicrobial prescribing in residential homes. J Antimicrob Chemother 67, 1781–1790 (2012).

    Hughes C. , 'Antimicrobial prescribing in residential homes ' (2012 ) 67 J Antimicrob Chemother : 1781 -1790.

    • Search Google Scholar
  • Schwartz, D.N., Adiad, H., DeMarais, P.L., Armeanu, E., Trick, W.E., Wang, Y., Weinstein, R.A.: An educational intervention to improve antimicrobial use in a hospital-based long-term care facility. J Am Geriatr Soc 55, 1236–1242 (2007).

    Weinstein R.A. , 'An educational intervention to improve antimicrobial use in a hospital-based long-term care facility ' (2007 ) 55 J Am Geriatr Soc : 1236 -1242.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 7 1 2
Mar 2021 7 0 0
Apr 2021 7 0 0
May 2021 12 0 0
Jun 2021 2 1 1
Jul 2021 1 0 0
Aug 2021 0 0 0